Reproductive toxicity testing of vaccines

Toxicology

Volumn 185, Issue 3, 2003, Pages 213-219

  Verdier, François ^a   Barrow, Paul C ^b   Burge, Joëlle ^a  

^a SANOFI PASTEUR   (France)

^b MDS Pharma Services   (France)

Author keywords

Developmental immuno toxicology; Pregnancy; Reproductive toxicology; Teratology; Vaccines

Indexed keywords

MATERNAL ANTIBODY; VACCINE;

CONFERENCE PAPER; DEVELOPMENTAL STAGE; HUMAN; IMMUNE SYSTEM; IMMUNOGENICITY; MEDICAL ASSESSMENT; NONHUMAN; PERINATAL PERIOD; PHYSICAL EXAMINATION; PREGNANCY; PRENATAL PERIOD; PRIORITY JOURNAL; PROGENY; RABBIT; REPRODUCTIVE TOXICITY; RODENT; TOXICITY TESTING;

ABNORMALITIES, DRUG-INDUCED; ADULT; ANIMALS; FEMALE; GUIDELINES; HUMANS; IMMUNITY, MATERNALLY-ACQUIRED; IMMUNOGLOBULINS; LEGISLATION, MEDICAL; MENINGOCOCCAL VACCINES; NEISSERIA MENINGITIDIS, SEROGROUP B; PREGNANCY; REPRODUCTION; TERATOGENS; VACCINES;

ANIMALIA; BACTERIA (MICROORGANISMS); ORYCTOLAGUS CUNICULUS; RODENTIA;

EID: 0037392978     PISSN: 0300483X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0300-483X(02)00611-X     Document Type: Conference Paper

References (26)

1. Barrow, P.C., 2003. Reproductive toxicity studies and immunotherapeutics. Toxicology, 185, PII S0300-483X(02)00610-8.
2. Buse, E., Habermann, G., Osterburg, I., Korte, R., Weinbauer, G.F., 2003. Reproductive/developmental toxicity and immunotoxicity assessment in the nonhuman primate model. Toxicology, 185, PII S0300-483X(02)00614-5.
3. Centers for Disease Control and Prevention, 1999. Prevention and control of influenza: recommendations of the Advisory Committee on Immunization Practices. MMWR, 48.
4. Cookson W. The alliance of genes and environment in asthma and allergy. Nature. 402:(Suppl. B):1999;5-11.
5. Coquillat D., Bruge J., Danve B., Latour M., Hurpin C., et al. Activity and cross-reactivity of antibodies induced in mice by immunization with a group B meningococcal conjugate. Infect. Immun. 69:2001;7130-7139.
6. DeSesso J.M. Comparative embryology. Hood R.D. Handbook of Developmental Toxicology. 1997;111-174 CRC Press, Boca Raton.
7. EEC, 1991. Commission Directive 91/507/EEC of 19 July 1991 modifying the Annex to Council Directive 75/318/EEC on the approximation of the laws of Member States relating to analytical, pharmacotoxicological and clinical standards and protocols in respect of the testing of medicinal products. EEC Official J., L 270, 32-52.
8. EMEA, 1997. Note for guidance on pre-clinical pharmacological and toxicological testing of vaccines. CPMP/SWP/465/95.
9. EMEA, 2002. Note for guidance on the development of vaccinia based vaccines against smallpox. CPMP/1100/02.
10. Faustman, E.M., Ponce, A.R., Seeley, M.R., Whittaker, S.G., 1997. Experimental approaches to evaluate mechanisms of developmental toxicity. In: Hood, R.D. (Ed.). Handbook of Developmental Toxicology. CRC Press, Boca Raton, pp. 13-41.
11. FDA, 2000. Considerations for reproductive toxicity studies for preventive vaccines for infectious disease indications. http://www.fda.gov/cber/gdlns/reprotox.pdf .
12. Häyrinen J., Pelkonen S., Finne J. Structural similarity of the type-specific group B streptococcal polysaccharides and the carbohydrate units of tissue glycoproteins: evaluationof possible cross-reactivity. Vaccine. 7:1989;217-224.
13. Häyrinen J., Jennings H., Raff H.V., Rougon G., Hanai N., Gerardy-Schahn R., Finne J. Antibodies to polysialic acid and its N-propyl derivative: binding properties and interaction with human embryonal brain glycopeptides. J. Infect. Dis. 171:1995;1481-1490.
14. Holt P.G., et al. The role of allergy in the development of asthma. Nature. 402:(Suppl. B):1999;12-17.
15. Step 4 tripartite harmonised guidelines. Detection of toxicity to reproduction for medicinal products. D'Arcy P.F., Harron D.W.G. Proceedings of the Second International Conference on Harmonisation Orlando. 1994;557-578 Queen's University, Belfast.
16. Lee J.Y., Bowden D.S. Rubella virus replication and links to teratogenicity. Clin. Microbiol. Rev. 13:2000;571-587.
17. Maral I., Cirak M., Aksakal F.N., Baykan Z., Kayikcioglu F., Bumin M.A. Tetanus immunization in pregnant women: evaluation of maternal tetanus vaccination status and factors affecting rate of vaccination coverage. Public Health. 115:2001;359-364.
18. Mayerhofer A., Lahr G., Seidl K., Eusterschulte B., Christoph A., Gratzl M. The neural cell adhesion molecule (NCAM) provides clues to the development of testicular Leydig cells. J. Androl. 17:1996;223-230.
19. Munoz F.M., Englund J.A. A step ahead: infant protection through maternal immunization. Pediatr. Clin. North Am. 47:2000;449-463.
20. Pon R.A., Lussier M., Yang Q.L., Jennings H.J. N-Propionylated group B meningococcal polysaccharide mimics a unique bactericidal capsular epitope in group B Neisseria meningitidis. J. Exp. Med. 2:(185):1997;1929-1938.
21. Santosham M., Englund J.A., McInnes P., Croll J., Thompson C.M., Croll L., Glezen W.P., Siber G.R. Safety and antibody persistence following Haemophilus influenzae type b conjugate or pneumococcal polysaccharide vaccines given before pregnancy in women of childbearing age and their infants. Pediatr. Infect. Dis. J. 20:2001;931-940.
22. Schardein J.L. Immunological agents. Chemically Induced Birth Defects. third ed: 2000;613-630 Marcel Dekker, New York.
23. Schlamowitz M. Membrane receptors in the specific transfer of immunoglobulins from mother to young. Immunol. Commun. 5:1976;481-500.
24. Silim A., Rekik M.-R., Roy M.-S., Salmon H., Pastoret P.-P. Immunité chez le foetus et le nouveau-né Pastore P.P., Govaerts A., Bazin H. Immunologie Animale. 1990;197-204 Flammarion, Paris.
25. Thellin, O., Heinen, E., 2003. Pregnancy and the immune system: between tolerance and rejection. Toxicology, 185, PII S0300-483X(02)00607-8.
26. Zinkernagel R.M. Maternal antibodies, childhood infections, and autoimmune diseases. New Engl. J. Med. 345:2001;1331-1335.